Lukewarm reception to FDA biosimilar plan
The Perelman School of Medicine’s Holly Fernandez Lynch expressed ethical concerns over the selective availability of costly experimental medical treatments.
・ From Politico.com
The Perelman School of Medicine’s Holly Fernandez Lynch expressed ethical concerns over the selective availability of costly experimental medical treatments.
・ From Politico.com